| Highly potent multimeric E-selectin antagonists |
2023-7-06 |
2023-7-27 |
|
| Galactopyranosyl-cyclohexyl derivatives as E-selectin antagonists |
2023-1-06 |
2023-2-24 |
|
| Compositions and methods for overcoming microenvironment-mediated resistance … |
2022-8-02 |
2023-2-09 |
|
| Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or … |
2022-7-28 |
2023-4-27 |
|
| Galectin-3 inhibiting c-glycosides |
2022-5-13 |
2022-11-17 |
|
| Galectin-3 inhibiting c-glycoside oximes |
2022-5-13 |
2022-12-01 |
|
| E-selectin antagonist compounds, compositions, and methods of use |
2022-4-20 |
2023-3-30 |
|
| Process for preparing an e-selectin inhibitor intermediate |
2022-2-17 |
2023-8-17 |
|
| Process for preparing an e-selectin inhibitor intermediate |
2022-2-17 |
2022-4-01 |
|
| Use of highly potent multimeric e-selectin antagonists for treating sickle cell … |
2022-1-24 |
2022-3-01 |
|
| E-selectin targeting agents |
2021-9-17 |
2022-3-24 |
|
| Compositions and methods for overcoming microenvironment mediated resistance … |
2021-6-11 |
2023-4-28 |
|
| Compounds and methods for reduction of cancer cell burden and protection of … |
2021-5-28 |
2023-4-05 |
|
| Cd33 ligands suitable for incorporation into carriers |
2021-4-30 |
2023-3-08 |
|
| Cd33 ligands suitable for incorporation into carriers |
2021-4-30 |
2023-3-08 |
|
| Treatment of acute respiratory distress syndrome and related conditions with … |
2021-3-26 |
2023-5-11 |
|
| Galectin-3 inhibiting c-glycoside ketones, ethers, and alcohols |
2020-12-23 |
2023-3-23 |
|
| Galectin-3 inhibiting c-glycosides |
2020-10-27 |
2021-5-06 |
|
| Use of e-selectin antagonists to enhance the survival of reconstituted, bone … |
2020-7-31 |
2021-2-04 |
|
| Methods for use of gene expression as an indicator of e-selectin inhibitor … |
2020-7-12 |
2022-8-25 |
|
| Multimeric pan–selectin antagonists |
2020-4-21 |
2020-10-29 |
|
| Galactose-linked multimeric glycomimetic inhibitors of e-selectins, galectin-3, … |
2020-4-21 |
2020-10-29 |
|
| Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors |
2020-3-13 |
2020-6-11 |
|
| Selectin or galectin antagonists for treating cytokine release syndrome and crs … |
2020-1-14 |
2021-11-24 |
|
| Heterobifunctional inhibitors of e-selectin and galectin-3 |
2019-12-26 |
2022-3-24 |
|
| C-glycoside inhibiting galectin-3 |
2019-12-26 |
2021-10-08 |
|
| Methods of treating hiv and aids and the elimination of latent reservoirs of … |
2019-12-10 |
2020-8-06 |
|
| Methods of treatment of acute myeloid leukemia and related conditions |
2019-3-04 |
2020-11-11 |
|
| Heterobifunctional inhibitors of E-selectin and galectin-3 |
2018-12-28 |
2023-7-13 |
2023-7-13 |
| Methods of mobilizing marrow infiltrating lymphocytes and uses thereof |
2018-11-29 |
2021-6-17 |
|
| UNIONS, COMPOSITIONS AND METHODS USING CELLTIC E COMPONENTS FOR MOVEMENT OF … |
2018-5-07 |
2018-12-12 |
|
| PAN-SELECTIN HYDRODERUTICAL SUSPENSIONS |
2017-12-27 |
2018-6-27 |
|
| Haloalkyl fucose-containing selectin antagonists |
2017-5-22 |
2017-11-30 |
|
| Methods for the treatment and/or prevention of cardiovascular disease by … |
2017-3-01 |
2022-4-05 |
2022-4-05 |
| Glycomimetic inhibitors of pa-il and pa-iil lectins |
2017-1-18 |
2017-7-27 |
|
| Heterobifunctional pan-selectin antagonists having a triazole linker |
2016-11-30 |
2018-10-10 |
|
| Methods and compositions for the production of monoclonal antibodies, … |
2016-11-02 |
2017-5-11 |
|
| Antibodies for targeting cancer stem cells and treating aggressive cancers |
2016-11-02 |
2018-5-17 |
|
| Methods for the mobilization and use of t-cells with enhanced reconstitution … |
2016-8-02 |
2017-2-09 |
|
| Glycomimetic compounds and methods to inhibit infection by hiv |
2016-6-15 |
2016-10-06 |
|
| E-selectin inhibition works in combination with low-molecular weight heparin to … |
2016-5-13 |
2016-11-17 |
|
| 2-halo-galactose-containing selectin antagonists |
2016-4-06 |
2016-10-13 |
|
| Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors |
2015-12-01 |
2022-6-28 |
|
| COMPOUND, COMPOSITION AND USE THEREOF |
2015-12-01 |
2023-6-27 |
|
| E-selectin antagonists modified by macrocycle formation to the galactose |
2015-1-15 |
2015-7-23 |
|
| Pan-selectin inhibitor with enhanced pharmacokinetic activity |
2014-10-28 |
2015-2-19 |
|
| Methods and compositions for treating and/or preventing mucositis |
2014-9-29 |
2015-4-02 |
|
| Compounds and methods to enhance the oral availability of glycomimetics |
2014-3-06 |
2014-9-25 |
|
| Compounds and methods to enhance the oral availability of glycomimetics |
2013-10-31 |
2014-5-08 |
|
| Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists |
2013-10-31 |
2014-7-17 |
|
| Glycomimetic replacement for hexose and n-acetyl hexosamine |
2013-6-17 |
2013-9-26 |
|
| Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors |
2013-3-05 |
2013-7-18 |
|
| PAN-SELECTIN HYDRODERUTICAL SUSPENSIONS |
2012-12-27 |
2016-6-22 |
|
| E-selectin antagonist compounds, compositions, and methods of use |
2012-12-21 |
2017-1-05 |
|
| Glycomimetic inhibitor of pa-il lectin, pa-iil lectin or both the lectins from … |
2012-12-06 |
2013-3-14 |
|
| Treatment of cancers of the blood using selected glycomimetic compounds |
2011-12-08 |
2012-7-20 |
|
| Glycomimetic-peptidomimetic inhibitors of e-selectins and cxcr4 chemokine … |
2011-11-03 |
2012-5-10 |
|
| Anti-epileptogenic agents |
2011-10-04 |
2012-4-12 |
|
| Compounds and methods for treatment of sickle cell disease or complications … |
2011-9-23 |
2012-1-19 |
|
| E-selectin antagonists |
2011-9-12 |
2014-12-30 |
2014-12-30 |
| Methods of use of glycomimetics with replacements for hexoses and n-acetyl … |
2011-9-02 |
2012-8-09 |
|
| Detection and treatment of prostate cancer |
2010-4-13 |
2011-2-03 |
|
| Compounds and methods for inhibiting selectin-mediated function |
2010-4-02 |
2010-11-04 |
|
| Glycomimetic inhibitors of siglec-8 |
2007-6-19 |
2009-7-09 |
|
| Galactosides and thiodigalactosides as inhibitors of pa-il lectin from … |
2007-5-30 |
2009-7-09 |
|
| Heterobifunctional compounds for selectin inhibition |
2006-5-24 |
2009-2-05 |
|
| Glycomimetic antagonists for both E-and P-selectins |
2004-11-18 |
2005-8-25 |
|
| Specific antagonist for both e- and p-selectins |
2004-11-18 |
2008-1-09 |
2008-1-09 |
| Oligosaccharides and conjugates thereof for the treatement of pseudomonas … |
2003-12-19 |
2004-7-15 |
|
| Compositions and methods for diagnosis and therapy of medical conditions … |
2003-12-19 |
2004-11-04 |
|
| Compositions and methods for diagnosis and therapy of medical conditions … |
2003-6-19 |
2009-2-25 |
|
| Composto, composição e uso dos mesmos |
2015-12-01 |
2023-6-27 |
|